Methyl 4-((4-methylpiperazin-1-yl)methyl)benzoate, 95.0%, 5g

PYRIDAZINE, 3,6-DICHLORO-4-(1-METHYLETHYL)-, 95.0%, 5g

(R)-1-(3-Bromo-2-methylphenyl)ethanamine hydrochloride, 5g

(3R,4S)-1-(Tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid, 97%, 1g

(S)-1-Boc-2-Benzylpiperizine, 98.0%, 5g

HPLC column NUCLEODUR® NH2 5 µm, 125 mm, 4.6 mm, 1 Piece(s)

tert-Butyl (R)-2-ethynyl-2-methylpyrrolidine-1-carboxylate, 98%, 250mg

(4-(BIS(4-CHLOROPHENYL)METHYL)PIPERAZIN-1-YL)(5-METHYL-4-NITROISOXAZOL-3-YL)METHANONE, 95%, 100mg

anti-1,2,2,3,4,4-Hexamethylphosphetane 1-Oxide>98.0%(GC)1g

1-Benzyl-3-aminopyrrolidine>97.0%(GC)(T)5g

2-(Morpholinothio)benzothiazole>97.0%(GC)25g

(E)-(2-Nitrovinyl)benzene, 98.0%, 500g

Ethyl 2-(4-fluoro-phenylamino)-4-methyl-thiazole-5-carboxylate, 98.0%, 250mg